AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Eupraxia Pharmaceuticals Inc.

CAD 11.21 +$0.75 (+7.17%)
TSX · 14 Sep 2026 20:00 UTC
Previous Close
CAD 11.69
Day Range
CAD 11.13CAD 11.71
Year Range
CAD 7.15CAD 12.86
Market Cap
402.86M
AVG Volume
64.48K
Trailing/Forward PE
-7.91/-
PEG ratio
-0.55
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
Toronto Stock ExchangeCA
Net Income (USD) · TTM
-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-49.89M
26 Q1-44.52M
25 Q4-38.83M
25 Q3-29.37M
25 Q2-28.95M
25 Q1-24.6M
24 Q4-23.84M
24 Q3-26.54M
24 Q2-26.91M
24 Q1-30.35M
Operating Income (USD) · TTM
-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-56.63M
26 Q1-47.25M
25 Q4-38.68M
25 Q3-29.75M
25 Q2-29.14M
25 Q1-27.43M
24 Q4-26.96M
24 Q3-31.53M
24 Q2-34.14M
24 Q1-35.32M
EBITDA (USD) · TTM
-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-55.76M
26 Q1-44.63M
25 Q4-33.74M
25 Q3-24.88M
25 Q2-22.96M
25 Q1-20.78M
24 Q4-21.82M
24 Q3-22.26M
24 Q2-22.32M
24 Q1-27.28M
Cash Flows (USD) · TTM
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-36.57M
26 Q1-32.14M
25 Q4-28.01M
25 Q3-23.94M
25 Q2-28.21M
25 Q1-27.45M
24 Q4-27.36M
24 Q3-27.34M
24 Q2-27.76M
24 Q1-25.75M
EPS (USD) · TTM
-1.5-1-0.5024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.99
26 Q1-1.02
25 Q4-1
25 Q3-0.88
25 Q2-0.82
25 Q1-0.68
24 Q4-0.68
24 Q3-0.84
24 Q2-0.96
24 Q1-1.41
Expenses (USD) · TTM
020M40M60MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q257.03M
26 Q145.59M
25 Q434.73M
25 Q323.56M
25 Q221.3M
25 Q119.87M
24 Q421.32M
24 Q328.18M
24 Q232.57M
24 Q134.11M
Shares Outstanding (USD) · TTM
-10M-7.5M-5M-2.5M0Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPRX.TO Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-8.55M
26 Q1-9.67M
25 Q4-8.91M
25 Q3-3.96M
25 Q2-4.01M
25 Q1-3.97M
24 Q4-2.69M
24 Q3-1.91M
24 Q2-2.01M
24 Q1-1.62M
Free Cash Flow Yield
-40%-30%-20%-10%0%med -13.52%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EPRX.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-7.01%
Sep 26-6.72%
Sep 26-6.73%
Aug 26-8.49%
Aug 26-8.39%
Aug 26-8.44%
Aug 26-8.35%
Jul 26-8.84%
Jul 26-9.72%
Jul 26-8.57%
Jul 26-8.48%
Jul 26-8.45%
Jun 26-8.16%
Jun 26-8.42%
Jun 26-8.93%
Jun 26-9.02%
May 26-7.49%
May 26-7.68%
May 26-7.77%
May 26-7.15%
May 26-6.82%
Apr 26-7.46%
Apr 26-7.58%
Apr 26-7.84%
Apr 26-7.54%
Mar 26-10.67%
Mar 26-10.02%
Mar 26-9.67%
Mar 26-8.89%
Feb 26-8.76%
Feb 26-8.37%
Feb 26-8.48%
Feb 26-8.53%
Jan 26-8.66%
Jan 26-7.93%
Jan 26-8.13%
Jan 26-8.84%
Jan 26-9.39%
Dec 25-9.76%
Dec 25-10.83%
Dec 25-11.41%
Dec 25-11.57%
Nov 25-11.44%
Nov 25-11.35%
Nov 25-10.78%
Nov 25-13.08%
Oct 25-13.75%
Oct 25-14.37%
Oct 25-13.56%
Oct 25-13.09%
Oct 25-13.47%
Sep 25-13.42%
Sep 25-12.87%
Sep 25-14.48%
Sep 25-14.42%
Aug 25-14.24%
Aug 25-14.5%
Aug 25-14.41%
Aug 25-14.67%
Aug 25-14.48%
Jul 25-13.95%
Jul 25-14.65%
Jul 25-13.79%
Jul 25-13.67%
Jun 25-14.28%
Jun 25-17.48%
Jun 25-19.48%
Jun 25-19.79%
May 25-19.74%
May 25-20.03%
May 25-20.04%
May 25-19.8%
May 25-19.24%
Apr 25-19.9%
Apr 25-23.28%
Apr 25-25.7%
Apr 25-26.31%
Mar 25-23.08%
Mar 25-20.98%
Mar 25-18.47%
Mar 25-18.34%
Feb 25-19.47%
Feb 25-20.66%
Feb 25-24.02%
Feb 25-23.83%
Jan 25-25.05%
Jan 25-25.3%
Jan 25-24%
Jan 25-25.61%
Jan 25-25.25%
Dec 24-25.01%
Dec 24-25.86%
Dec 24-22.86%
Dec 24-25.01%
Nov 24-22.87%
Nov 24-22.18%
Nov 24-25.06%
Nov 24-24.62%
Nov 24-25.27%
Oct 24-31.55%
Price to Book
05101520med 4.52Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EPRX.TO Price to Book by quarter
PeriodPrice to Book
Sep 263.36
Sep 263.51
Sep 263.5
Aug 262.78
Aug 262.81
Aug 262.79
Aug 262.82
Jul 262.67
Jul 262.43
Jul 262.75
Jul 262.78
Jul 262.79
Jun 264.28
Jun 264.14
Jun 263.91
Jun 263.87
May 264.66
May 264.54
May 264.49
May 264.88
May 265.12
Apr 264.68
Apr 264.6
Apr 264.45
Apr 264.62
Mar 262.54
Mar 262.71
Mar 262.81
Mar 263.05
Feb 263.1
Feb 263.24
Feb 263.2
Feb 263.18
Jan 263.14
Jan 263.42
Jan 263.34
Jan 263.07
Jan 262.89
Dec 252.78
Dec 252.51
Dec 252.38
Dec 252.35
Nov 252.37
Nov 252.39
Nov 252.52
Nov 252.07
Oct 259.78
Oct 259.36
Oct 259.92
Oct 2510.27
Oct 259.98
Sep 257.57
Sep 257.89
Sep 257.01
Sep 257.04
Aug 257.13
Aug 257
Aug 257.04
Aug 256.92
Aug 257.01
Jul 257.28
Jul 256.93
Jul 257.36
Jul 257.43
Jun 256.02
Jun 254.92
Jun 254.41
Jun 254.34
May 254.35
May 254.29
May 254.29
May 254.34
May 254.47
Apr 254.32
Apr 253.69
Apr 253.34
Apr 253.27
Mar 2514.85
Mar 2516.34
Mar 2518.55
Mar 2518.69
Feb 2517.6
Feb 2516.59
Feb 2514.27
Feb 2514.38
Jan 2513.68
Jan 2513.55
Jan 2514.28
Jan 2513.38
Jan 2513.57
Dec 248.32
Dec 248.05
Dec 249.1
Dec 248.32
Nov 249.1
Nov 249.39
Nov 248.31
Nov 248.45
Nov 248.24
Oct 246.6
Eupraxia Pharmaceuticals Inc.
EPRX.TO
Stockpicker

Video analysis: EPRX.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.